RevErsing Poor GrAft Function With eLtrombopag After allogeneIc Hematopoietic Cell trAnsplantation
Clinical trial NCT03948529 · TERMINATED
Trial details
- NCT number
- NCT03948529
- Sponsor
- University Hospital, Lille
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-09-05
- Primary completion
- 2023-02-24
- Enrollment
- 9
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.